AI assistant
Sending…
STAAR SURGICAL CO — Director's Dealing 2014
Mar 12, 2014
31996_dirs_2014-03-11_f3b0e0b2-e4e8-4d77-b7d7-69cb0dc12b1f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: STAAR SURGICAL CO (STAA)
CIK: 0000718937
Period of Report: 2014-03-07
Reporting Person: Caldwell Barry G (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-03-07 | Common Stock | A | 17000 | — | Acquired | 283839 | Direct |
| 2014-03-07 | Common Stock | A | 30000 | — | Acquired | 313839 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-03-07 | Common Stock Options | $15.54 | A | 36000 | Acquired | 2024-03-06 | Common Stock (36000) | Direct |
Footnotes
F1: Consists of 17,000 Restricted Shares of Common Stock (PARS), subject to forfeiture rights, which lapse as to 1/2 of the shares (8500 shares) on 3/7/16,and lapse as to the other 1/2 of the shares (8500 shares) on 3/7/17.
F2: Includes 30,000 PARS.
F3: The options first become exercisable as follows: 12,000 shares on 3/7/15, 12,000 shares on 3/7/16 and 12,000 shares on 3/7/17.
F4: Consists of 30,000 performance-contingent restricted shares pursuant to the 2013 RSU Plan which vested on 3/7/14.
More from STAAR SURGICAL CO
Interim / Quarterly Report
2026
May 13
Regulatory Filings
2026
May 13
Major Shareholding Notification
2026
May 12
Annual Report
2026
May 4
Proxy Solicitation & Information Statement
2026
May 4
Proxy Solicitation & Information Statement
2026
May 4
Major Shareholding Notification
2026
Apr 24
Major Shareholding Notification
2026
Apr 20
Regulatory Filings
2026
Apr 8
Major Shareholding Notification
2026
Mar 27